Conexeu Sciences Appoints Jean-Romain (JR) Falconnet as Head of Business Development & Licensing
Reno, Nevada--(Newsfile Corp. - March 2, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular matrix platform, is pleased to announce Jean-Romain (JR) Falconnet as Head of Business Development & Licensing. In his role at Conexeu, JR will lead business development, licensing strategy, and strategic partnerships—supporting the company's growth roadmap and expanding op
Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-02 9:03 AM EST | Conexeu Sciences Inc.
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing next-generation therapeutics using its proprietary Accum® platform, today outlined its participation in a series of major international industry events taking place in March 2026. These high-profile meetings will provide Defence with multiple opportunities to advance strategic p
Biotechnology, Pharmaceuticals, Health
2026-03-02 3:15 AM EST | Defence Therapeutics Inc.
Delivra Health and Its Brands LivRelief (TM) and Dream Water (TM) Report Results for Second Quarter of Fiscal 2026
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Delivra Health Brands Inc. (TSXV: DH
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-02-27 6:45 PM EST | Delivra Health Brands Inc.
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
Montreal, Quebec--(Newsfile Corp. - February 27, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the launch of a private placement (the "Private Placement") of up to 20,000,000 units (the "Units") at a price of $0.55 per Unit, for aggregate gross proceeds to Defence of up to $11,000,000. Each Unit will be compris
Biotechnology, Pharmaceuticals, Health
2026-02-27 5:00 PM EST | Defence Therapeutics Inc.
Communities Nationwide Rally This March to Support Lifesaving Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - February 27, 2026) - This March, communities across the country will unite in support of the St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants in the U.S., in a nationwide effort to Conquer Kids' Cancer. From local schools, fire and police departments, pubs and restaurants, workpl
2026-02-27 3:00 PM EST | St. Baldrick's Foundation
First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico
Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-02-27 8:30 AM EST | Akanda Corp
Restart Life Sciences Closes Acquisition of Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that it has successfully closed the previously announced acquisition of 100% of the issued and outstanding shares of Holy Crap Foods Inc. ("Holy Crap") pursuant to the definitive agreement dated February 12, 2026, among the Company, Happy Belly Coffee Inc., a subsidiary of Happy Belly Food Group
Technology, Biotechnology, Health
2026-02-27 8:00 AM EST | Restart Life Sciences Corp.
QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, is pleased to announce a non-brokered private placement. The Company intends to issue (the "Offering") of up to 10,000,000 units (each, a "Unit") at a price of C$0.05 per Unit, for aggregate gross proceeds to the Company of up to C$500,000. Each Unit will be comprised of one commo
2026-02-26 5:30 PM EST | QScreen AI Inc.
DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular diagnostics, is pleased to announce that it has obtained all required regulatory and ethics approvals to proceed with the clinical study of TeaRx™ Red Eye previously announced in a press release dated December 2, 2025. As previously disclosed, the Company initiated a collaboration
2026-02-26 5:00 PM EST | DiagnosTear Technologies Inc.
New National Polling Shows Strong Support for Prevention-Focused Dental Hygiene Care While Gaps in Access to Care Persist
Ottawa, Ontario--(Newsfile Corp. - February 26, 2026) - New national public opinion research released today by the Canadian Dental Hygienists Association (CDHA) shows Canadians place exceptionally high trust in dental hygienists and strongly support prevention-focused dental hygiene care, while also acknowledging that barriers to access remain. The polling, conducted by Abacus Data, found that 96 per cent of Canadians hold a positive impression of dental hygienists, with more than eight in te
Healthcare and Hospitals, Health
2026-02-26 9:40 AM EST | Canadian Dental Hygienists Association
Un nouveau sondage national montre un soutien massif aux soins d'hygiène dentaire axés sur la prévention tandis que des obstacles à l'accès aux soins persistent
Ottawa, Ontario--(Newsfile Corp. - 26 février 2026) - Une nouvelle recherche sur l'opinion publique nationale publiée aujourd'hui par l'Association canadienne des hygiénistes dentaires (ACHD) indique que les Canadiennes et Canadiens accordent une confiance exceptionnellement élevée aux hygiénistes dentaires et sont très favorables aux soins d'hygiène dentaire axés sur la prévention tout en reconnaissant la persistance d'obstacles à l'accè
Healthcare and Hospitals, Health
2026-02-26 9:40 AM EST | Canadian Dental Hygienists Association
OTF + Lilly Collaboration Update on Registration Response | OMA QI Scaling Initiative Gains National Response, Bringing Together Diverse Practice Types Across 39 States
Denver, Colorado--(Newsfile Corp. - February 26, 2026) - The Obesity Medicine Association (OMA) is seeing strong early momentum for its Implementation into Practice Collaborative (IPC), a program designed to help clinicians strengthen obesity care through practical, evidence-based improvements in outpatient settings. The IPC is part of a multi-phase Quality Improvement (QI) initiative created specifically for OMA members. It was developed in collaboration with the Obesity Treatment Foun
Healthcare and Hospitals, Health
2026-02-26 8:00 AM EST | Obesity Medicine Association
LevelJump Announces Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company") announces that, pursuant to the Company's 2022 Equity Incentive Plan, it has granted an aggregate of 2,250,000 incentive stock options (the "Options") to three directors of the Company. Each Option entitles the optionee to acquire one common share of the Company at an exercise price of $0.065 per common share until February 24, 2031. There are no vesting restrictions
Healthcare and Hospitals, Health
2026-02-26 8:00 AM EST | LevelJump Healthcare Corp.
Aleen Inc. Announces Its Listing on the Frankfurt Stock Exchange
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, is pleased to announce that its shares have officially commenced trading on the Frankfurt Stock Exchange (XFRA) since February 25, 2026. The listing marks a significant milestone in Aleen Inc.'s global growth strategy and strengthens the Company's presence in the European capital markets. By joining one of the world's leading financial exchanges, Aleen Inc. expands access to in
2026-02-26 8:00 AM EST | Aleen Inc.
Rock Salt Marketing Ranked Among Best SEO Agencies in the USA on DesignRush
Salt Lake City, Utah--(Newsfile Corp. - February 26, 2026) - Rock Salt Marketing Cooperative has been named one of the Best SEO Agencies in the USA by DesignRush, following the platform's latest review of search engine optimization firms across the country.
Real Estate, Travel, Health, Legal
2026-02-26 7:45 AM EST | Rock Salt Marketing Cooperative
TempraMed Reports over 275 Clinicians Recommending VIVI Cap to Patients on Leading FrontrowMD Platform Across the United States
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that more than 275 physicians across the United States have recommended and included VIVI Cap in the offers available to their patients across FrontrowMD, a leading physician engagement and education platform.
Technology, Biotechnology, Pharmaceuticals, Health
2026-02-26 7:00 AM EST | TempraMed Technologies Ltd.
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical-grade psychedelic drug products, today reported that patients diagnosed with treatment-resistant depression (TRD) have now been treated in Australia using the Company's naturally derived 5 mg psilocybin capsules under the Authorised Prescriber Scheme. The clinical a
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-02-26 7:00 AM EST | Optimi Health Corp.
Optimi Health berichtet über den frühen klinischen Einsatz natürlicher Psilocybin-Kapseln zur Behandlung therapieresistenter Depressionen in Australien
Vancouver, British Columbia--(Newsfile Corp. - Donnerstag, 26. Februar 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" oder das "Unternehmen"), ein von Health Canada lizenzierter Hersteller pharmazeutischer Psychedelika-Produkte in pharmazeutischer Qualität, gab heute bekannt, dass in Australien nun Patienten mit therapieresistenter Depression (TRD) unter dem Authorised Prescriber Scheme mit den natürlich gewonnenen 5-mg-Psilocybin-Kapseln d
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-02-26 7:00 AM EST | Optimi Health Corp.
Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health
Sacramento, California--(Newsfile Corp. - February 25, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that, further to its February 18t
2026-02-25 8:00 AM EST | Izotropic Corporation
Aleen Inc. Advances Personal Account Infrastructure Following AI Agent Development
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, announces continued internal progress in strengthening its Personal Account infrastructure following the previously announced development of Wellness AI Agents. Building on its AI agent framework, Aleen Inc. is optimizing the integration of these assistive tools within the Personal Account environment. Current improvements focus on enhancing internal system performance, increas
2026-02-25 8:00 AM EST | Aleen Inc.